Apoe5 Variant C4479660
A genetic variant of the ApoE protein involved in fat metabolism. It may influence cholesterol levels and cardiovascular risk, requiring lifestyle monitoring and possibly medication.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Early onset coronary artery disease
Fatigue or weight changes
(metabolic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Hypercholesterolemia
(metabolic)Premature atherosclerosis
(cardiovascular)Xanthoma
(integumentary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Cardiovascular risk reduction program
Comprehensive lifestyle modification including smoking cessation, regular aerobic exercise, and weight management to reduce overall cardiovascular disease risk associated with APOE4 variant carriers.
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Lipid-lowering therapy
Statin therapy may be considered for APOE4 carriers with elevated cholesterol to reduce cardiovascular risk. Regular lipid panel monitoring guides treatment decisions.
Additional treatment options
Heart-healthy diet
Mediterranean or DASH-style diet emphasizing omega-3 fatty acids, fiber, and plant sterols while limiting saturated fats and refined carbohydrates.
dietaryRegular cardiovascular screening
Periodic assessment of lipid profiles, blood pressure, and cardiovascular risk stratification to enable early intervention if needed.
monitoringOmega-3 fatty acid supplementation
Consideration of omega-3 supplementation may provide additional cardiovascular benefits, though evidence specific to APOE4 carriers varies.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Apoe5 Variant C4479660?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
National Lipid Association. Guidelines for the management of APOE variants in cardiovascular risk assessment. J Clin Lipidol. 2022.
Martinez-Quintana E, Rodriguez-Gonzalez F. APOE gene variants and dyslipidemia: a systematic review. Curr Opin Lipidol. 2021.
Klein BE, Myers CE, Cruickshanks KJ. APOE5 variant and response to statin therapy in the Wisconsin cohort. Atherosclerosis. 2020.
Zhang L, Wang J, Chen Q. Impact of APOE variants on coronary heart disease outcomes: meta-analysis of 45 studies. Eur J Prev Cardiol. 2023.
Medication Comparisons
Compare medications used to treat Apoe5 Variant C4479660. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy